© 1995 American Heart Association, Inc.
Articles |
Recombinant Apolipoprotein A-IMilano Dimer Inhibits Carotid Intimal Thickening Induced by Perivascular Manipulation in Rabbits
From the Institute of Pharmacological Sciences and Center E. Grossi Paoletti, University of Milano (Italy).
Correspondence to Dr Maurizio Soma, Institute of Pharmacological Sciences, via Balzaretti 9, 20133 Milano, Italy.
Abstract Apolipoprotein A-IMilano
(apoA-IM), a natural variant of apolipoprotein A-I
(apoA-I), confers to the carriers a significant protection against
vascular disease. The antiatherogenic activity of a recombinant
disulfide-linked apoA-IM dimer
(rA-IM/A-IM) was analyzed in vivo by
evaluating its effect on neointimal formation induced by
periarterial manipulation in 1% cholesterol–fed rabbits. A flexible
collar was applied around the carotid artery 21 days after the
beginning of the dietary regimen, and animals were killed 10 days
later. Rabbits were injected five times with reconstituted high-density
lipoprotein containing egg phosphatidylcholine (EPC) and
rA-IM/A-IM (119 mg EPC+40 mg protein per
dose) or with EPC liposomes (119 mg EPC per dose) beginning either 5
days before or at the day of collar positioning. Neither treatment
affected plasma cholesterol levels. A significant intimal thickening
was observed in control animals; the intima-to-media (I/M) ratio was
0.63±0.11 versus 0.03±0.05 for the sham-operated contralateral
arteries. Neointimal formation was markedly inhibited in animals
pretreated with rA-IM/A-IM before lesion
induction (I/M, 0.26±0.19) but not in those in which treatment
began the day of collar insertion (I/M, 0.74±0.14). EPC liposomes did
not affect neointimal formation (I/M, 0.50±0.14 and
0.51±0.07 in the two treatment groups). Proliferation of smooth muscle
cells, assessed by direct incorporation of bromo-2'-deoxyuridine (BrdU)
into replicating DNA, was reduced by 
30% and 75% in the intimal
and medial tissues of
rA-IM/A-IM–pretreated rabbits. Thus, a
short-term treatment with rA-IM/A-IM
inhibits smooth muscle cell proliferation and intimal thickening in
rabbits, providing evidence for the potential use of
rA-IM/A-IM in the treatment of
atherosclerosis.
Key Words: recombinant apolipoproteins • smooth muscle cell proliferation • atherosclerosis • restenosis
This article has been cited by other articles:
 |
|
 |
|
  C. Parolini, M. Marchesi, P. Lorenzon, M. Castano, E. Balconi, L. Miragoli, L. Chaabane, A. Morisetti, V. Lorusso, B. J. Martin, et al. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1098 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, K.-Y. Chyu, J. R. F. Neto, J. Yano, N. Nathwani, C. Ferreira, P. C. Dimayuga, B. Cercek, S. Kaul, and P. K. Shah Differential Effects of Apolipoprotein A-I-Mimetic Peptide on Evolving and Established Atherosclerosis in Apolipoprotein E-Null Mice Circulation, September 21, 2004; 110(12): 1701 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaul, B. Coin, A. Hedayiti, J. Yano, B. Cercek, K.-Y. Chyu, and P. K. Shah Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaul, V. Rukshin, R. Santos, B. Azarbal, C. L. Bisgaier, J. Johansson, V. T. Tsang, K.-Y. Chyu, B. Cercek, J. Mirocha, et al. Intramural Delivery of Recombinant Apolipoprotein A-IMilano/Phospholipid Complex (ETC-216) Inhibits In-Stent Stenosis in Porcine Coronary Arteries Circulation, May 27, 2003; 107(20): 2551 - 2554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chiesa, E. Monteggia, M. Marchesi, P. Lorenzon, M. Laucello, V. Lorusso, C. Di Mario, E. Karvouni, R. S. Newton, C. L. Bisgaier, et al. Recombinant Apolipoprotein A-IMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks Circ. Res., May 17, 2002; 90(9): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 692 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, J. Yano, O. Reyes, K.-Y. Chyu, S. Kaul, C. L. Bisgaier, S. Drake, and B. Cercek High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice : Potential Implications for Acute Plaque Stabilization Circulation, June 26, 2001; 103(25): 3047 - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Sirtori, L. Calabresi, G. Franceschini, D. Baldassarre, M. Amato, J. Johansson, M. Salvetti, C. Monteduro, R. Zulli, M. L. Muiesan, et al. Cardiovascular Status of Carriers of the Apolipoprotein A-IMilano Mutant : The Limone sul Garda Study Circulation, April 17, 2001; 103(15): 1949 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Bart De Geest, D. Stengel, M. Landeloos, M. Lox, L. Le Gat, D. Collen, P. Holvoet, and E. Ninio Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E-Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase : Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20 (10): e68 - e75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. P. Lardenoye, D. J. M. Delsing, M. R. de Vries, M. M. L. Deckers, H. M. G. Princen, L. M. Havekes, V. W. M. van Hinsbergh, J. H. van Bockel, and P. H. A. Quax Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE*3Leiden Transgenic Mice Circ. Res., August 4, 2000; 87(3): 248 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Baetta, M. Soma, C. De-Fraja, C. Comparato, C. Teruzzi, L. Magrassi, and E. Cattaneo Upregulation and Activation of Stat6 Precede Vascular Smooth Muscle Cell Proliferation in Carotid Artery Injury Model Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, J. Nilsson, S. Kaul, M. C. Fishbein, H. Ageland, A. Hamsten, J. Johansson, F. Karpe, and B. Cercek Effects of Recombinant Apolipoprotein A-IMilano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice Circulation, March 3, 1998; 97(8): 780 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 692 - 698. [Abstract] [Full Text] [PDF]
|
|